UiPath to Participate at Upcoming Investor Conferences
BMO 2025 Virtual Software Conference
Date:
Time: 10:00 am ET
Location: Virtual
Mizuho Technology Conference 2025
Date: Wednesday, June 11, 2025
Time: 2:05 pm ET
Location: Conrad New York Downtown
The presentation will be available via live audio webcast and archived replay on the Investor Relations section of the Company's website (https://ir.uipath.com).
About UiPath
UiPath (NYSE: PATH) is a global leader in agentic automation, empowering enterprises to harness the full potential of AI agents to autonomously execute and optimize complex business processes. The UiPath Platform™ uniquely combines controlled agency, developer flexibility, and seamless integration to help organizations scale agentic automation safely and confidently. Committed to security, governance, and interoperability, UiPath supports enterprises as they transition into a future where automation delivers on the full potential of AI to transform industries. For more information, visit www.uipath.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Haleon Breaks Ground on new £130m Global Oral Health Innovation Centre
LONDON--(BUSINESS WIRE)--This week, Haleon, a global leader in consumer health and maker of leading brands such as Sensodyne, parodontax and Polident, broke ground on its new Global Oral Health Innovation Centre in Weybridge, Surrey. This state-of-the-art facility will enhance Haleon's science capabilities, accelerate innovation, and serve as a centre of excellence for global oral health research. The groundbreaking ceremony, attended by UK Minister Baroness Jones, marks an important step in Haleon's ambition to reach one billion more consumers by 2030, by strengthening its oral health R&D capabilities to put health in more hands globally. Set to become the R&D epicentre for Haleon's oral health portfolio, the centre will be a dynamic hub for pioneering research, product innovation, commercial and supply chain excellence, and cross-functional collaboration. Equipped with the latest technology and global expertise, the centre will feature a cutting-edge digital immersive room designed to unlock value at pace through real-time collaboration with Haleon's manufacturing site in Levice. At the heart of the building, the atrium will create a vibrant hub for teamwork and co-creation, bringing leading expertise together to develop solutions that address unmet oral health needs for consumers around the world. Designed with sustainability at its core, the site has recently achieved a BREEAM® Outstanding rating, recognising its exceptional commitment to sustainability at Phase 1 in the design stage. Franck Riot, Chief R&D Officer, Haleon, said:" We are excited to break ground on our Global Oral Health Innovation Centre - a major investment reflecting our commitment to advancing science and innovation. This powerhouse for oral health research will strengthen Haleon's R&D capabilities and accelerate the development of cutting-edge solutions to meet the evolving oral health needs of consumers around the world. ' Chancellor of the Exchequer, Rachel Reeves MP, said: 'This exciting milestone is another demonstration of the strength of the UK life sciences sector, a key pillar to our Industrial Strategy. Under this government Britain is open for business, and through our Plan for Change we're delivering more investment, more jobs and more money in people's pockets.' UK Minister for Technology, Baroness Jones, said: 'Haleon is breaking ground on a new centre that will place the UK at the forefront of innovation to improve everyone's oral health - which we know is important to our wider health, and to children's development. This centre, and the substantial investment behind it, is proof that the UK's world-leading life sciences sector is the place to be to grow businesses and work on fresh ideas to transform healthcare. Leveraging these strengths will lead to the long-term economic growth that will help us deliver on our Plan for Change.' Jayant Singh, Global Category Lead, Oral Health, Haleon, said:" With oral diseases affecting nearly half the world's population, this marks an exciting step forward in our mission to put health in more hands for millions across the world. This centre will play a key role in harnessing the full potential of science and innovation across our oral health portfolio. ' About Haleon Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
Yahoo
an hour ago
- Yahoo
Media Stocks Q1 Teardown: The New York Times (NYSE:NYT) Vs The Rest
As the Q1 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the media industry, including The New York Times (NYSE:NYT) and its peers. The advent of the internet changed how shows, films, music, and overall information flow. As a result, many media companies now face secular headwinds as attention shifts online. Some have made concerted efforts to adapt by introducing digital subscriptions, podcasts, and streaming platforms. Time will tell if their strategies succeed and which companies will emerge as the long-term winners. The 7 media stocks we track reported a satisfactory Q1. As a group, revenues missed analysts' consensus estimates by 5.3%. Luckily, media stocks have performed well with share prices up 16.7% on average since the latest earnings results. Founded in 1851, The New York Times (NYSE:NYT) is an American media organization known for its influential newspaper and expansive digital journalism platforms. The New York Times reported revenues of $635.9 million, up 7.1% year on year. This print was in line with analysts' expectations, and overall, it was a strong quarter for the company with an impressive beat of analysts' EPS estimates and a decent beat of analysts' adjusted operating income estimates. The New York Times achieved the fastest revenue growth of the whole group. Unsurprisingly, the stock is up 8.4% since reporting and currently trades at $57.12. Is now the time to buy The New York Times? Access our full analysis of the earnings results here, it's free. Founded by brothers Walt and Roy, Disney (NYSE:DIS) is a multinational entertainment conglomerate, renowned for its theme parks, movies, television networks, and merchandise. Disney reported revenues of $23.62 billion, up 7% year on year, outperforming analysts' expectations by 2%. The business had a very strong quarter with an impressive beat of analysts' adjusted operating income estimates and a solid beat of analysts' EPS estimates. Disney delivered the biggest analyst estimates beat among its peers. The market seems happy with the results as the stock is up 34.7% since reporting. It currently trades at $124. Is now the time to buy Disney? Access our full analysis of the earnings results here, it's free. Launching the careers of legendary artists like Frank Sinatra, Warner Music Group (NASDAQ:WMG) is a music company managing a diverse portfolio of artists, recordings, and music publishing services worldwide. Warner Music Group reported revenues of $1.48 billion, flat year on year, falling short of analysts' expectations by 2.2%. It was a softer quarter as it posted a significant miss of analysts' EPS estimates and a miss of analysts' Recorded Music revenue estimates. As expected, the stock is down 2.2% since the results and currently trades at $29.43. Read our full analysis of Warner Music Group's results here. Originally launched as a soccer streaming platform, fuboTV (NYSE:FUBO) is a video streaming service specializing in live sports, news, and entertainment content. fuboTV reported revenues of $416.3 million, up 3.5% year on year. This print lagged analysts' expectations by 28.7%. Taking a step back, it was still a very strong quarter as it produced an impressive beat of analysts' EPS estimates and a solid beat of analysts' EBITDA estimates. fuboTV had the weakest performance against analyst estimates among its peers. The stock is up 27% since reporting and currently trades at $3.69. Read our full, actionable report on fuboTV here, it's free. Creator of the legendary Scholastic Book Fair, Scholastic (NASDAQ:SCHL) is an international company specializing in children's publishing, education, and media services. Scholastic reported revenues of $335.4 million, up 3.6% year on year. This result came in 3.5% below analysts' expectations. Aside from that, it was a mixed quarter as it also logged a solid beat of analysts' EPS estimates but full-year EBITDA guidance missing analysts' expectations. The stock is up 15.2% since reporting and currently trades at $21.63. Read our full, actionable report on Scholastic here, it's free. The Fed's interest rate hikes throughout 2022 and 2023 have successfully cooled post-pandemic inflation, bringing it closer to the 2% target. Inflationary pressures have eased without tipping the economy into a recession, suggesting a soft landing. This stability, paired with recent rate cuts (0.5% in September 2024 and 0.25% in November 2024), fueled a strong year for the stock market in 2024. The markets surged further after Donald Trump's presidential victory in November, with major indices reaching record highs in the days following the election. Still, questions remain about the direction of economic policy, as potential tariffs and corporate tax changes add uncertainty for 2025. Want to invest in winners with rock-solid fundamentals? Check out our Hidden Gem Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Can Circle Stock Hit $250 in 2025?
Circle Internet Group (CRCL), the issuer behind USDC (USDCUST), recently marked its debut on the New York Stock Exchange. On June 6, shares surged more than 29%, signaling strong market enthusiasm just a day after trading began. CRCL stock initially opened at $69 per share, more than double its initial public offering (IPO) price of $31. Notably, that IPO price also already exceeded the initially planned range of $27 to $28. By the end of its first session, CRCL stock had climbed even further, closing at $83.23. The remarkable rise has caught the attention of several analysts. Among them, Needham analyst John Todaro initiated coverage on CRCL with a 'Buy' rating, assigning a new Street-high price target of $250. Todaro emphasized the explosive growth potential within the stablecoin sector, describing it as a transformative force reshaping the financial ecosystem. 'It's a Miracle': Nvidia CEO Says Their New Technology Takes 'AI Supercomputing to a Whole New Level' AI Isn't Just About Nvidia: 2 Rising Stars in the Artificial Intelligence Race UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Given Circle's collaboration with Coinbase (COIN) on launching USDC, the company stands to be a prime beneficiary as adoption accelerates across both U.S. and global markets Furthermore, Todaro believes the passage of the GENIUS Act is a crucial catalyst for expanding stablecoin issuance and acceptance. A day after the act's approval, CRCL soared 34%. With expectations that Circle could secure a disproportionately large share of the expanding stablecoin market over the next five years, it's well worth watching the company's trajectory closely. Headquartered in New York, Circle operates as a leading fintech company specializing in stablecoins. With a market capitalization of $40 billion, it provides a comprehensive suite of stablecoins alongside a network utility and application platform designed to help organizations leverage the benefits of stablecoins and the internet-driven financial system. Circle's flagship product is a U.S. dollar-pegged stablecoin widely used in digital transactions. However, despite recent excitement, CRCL stock has faced some headwinds, dropping almost 12% over the past five trading days. The volatility accompanies premium valuations, with shares trading at approximately 175 times forward adjusted earnings and 21 times sales. These multiples sit well above the industry averages, reflecting investors' willingness to pay a premium for CRCL's potential and leadership position within the evolving stablecoin market. In fact, the company's elevated valuation points to a market that's betting heavily on future growth, even as near-term results remain a key focal point for investors balancing opportunity with risk. Circle delivered an impressive performance in the fiscal first quarter of 2025, which ended March 31. Total revenue and reserve income from continuing operations soared 58% year-over-year (YOY), reaching $578.6 million. Operating income from continuing operations climbed 77% YOY to $92.9 million. Adjusted EBITDA showed healthy growth as well, increasing 60.6% to $122.4 million. Net income expanded by 33% YOY, settling at $64.8 million. On an earnings per share basis, unaudited pro forma EPS came in at $0.29. Meanwhile, the company ended the quarter with a robust cash and cash equivalents position of $1.1 billion, providing ample liquidity for continued operations and growth initiatives. Looking ahead, analysts forecast a challenging second quarter. EPS for Q2 fiscal 2025 is projected to decline sharply by 100%, settling at -$1.89. The full fiscal year 2025 EPS is also expected to fall significantly by 100%, projected at -$1.32. However, optimism returns for fiscal 2026, where EPS is anticipated to increase by 134% to $0.45, reflecting a recovery and growth phase. These numbers suggest a transitional period marked by near-term pressure but an underlying confidence in the company's longer-term financial trajectory. In line with Needham's bullish stance, Bernstein initiated coverage on Circle with an 'Outperform' rating, setting a price target of $230. The analyst views Circle as a stablecoin 'category leader' and a critical player in the evolving payments landscape. Similarly, Canaccord Genuity assigned a 'Buy' rating on CRCL, targeting a price of $247 per share. CRCL stock currently holds a 'Moderate Buy' consensus rating. Out of the 12 analysts covering the stock, six analysts advocate for a 'Strong Buy,' one favors a "Moderate Buy," four recommend a 'Hold' rating, and one advises a 'Strong Sell.' The average price target of $193.12 represents marginal 3% potential upside. Meanwhile, the Street-High target of $250 suggests a potential climb of 32% from current levels. These evaluations underscore the market's expectation that Circle will continue to capitalize on accelerating stablecoin adoption and expand its foothold in the market. On the date of publication, Aanchal Sugandh did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
